Skip to content

Public FDA record

Z-0161-2027: IQ200 SPRINT, REF: 700-3322,700-3322RFB, 700-3325, 700-3326, B48997; IQ200 SELECT, REF: 700-3340, 700-334

Recall record Z-0161-2027 for Beckman Coulter, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0161-2027
Company in FDA record
Beckman Coulter, Inc.
FDA classification date
Oct 15, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The rinse-line check valve has a shorter service lifespan than originally expected and requires annual replacement to prevent lamina fluid leakage; however, the check valve replacement was excluded from the annual preventive maintenance (PM) requirements without adequate reliability evaluation. When the check valve is not replaced annually, it may allow lamina fluid to migrate internally and leak onto the table or floor, potentially resulting in exposure to physical hazards (slip/fall), chemical hazards (lamina fluid exposure), biohazardous exposure, property damage, and delayed patient results.

Source facts

Action
On 8/12/2026, recall notices were mailed and emailed to customers asking them to take the following actions: 1) Perform the daily Cleaning Instrument Surfaces maintenance described in Chapter 12, Maintenance Procedure of the DxU 840/850m Instructions for Use (PN# C49320AB), (PN# D38676AA), or iQ200 Instructions for Use (PN# 300-4320CE), (PN# 300-4321EE). During the cleaning, inspect the instrument for signs of lamina leakage, including fluid accumulation on or around the instrument, or evidence of fluid on the laboratory bench or floor. If you determine that there is a leak, discontinue use of the analyzer and clean any spilled fluid in accordance with your laboratory's safety procedure. 2) Contact the firm's Technical Support Organization immediately if evidence of leakage is observed. 3) Continue routine operation, if no leakage is observed, while maintaining increased awareness for the symptoms described in the impact section of this letter. 4) Post this letter on or near affected Analyzers. 5) Share this information with laboratory staff and retain this notification. If you have forwarded any of the affected products to another laboratory, please provide them a copy of this letter. Firm is investigating this issue and will continue to address any reported lamina fluid leakage through its Technical Support Organization until this issue has been fully resolved. If you have any questions regarding this notice, please contact the firm's Customer Support Center: http://www.beckmancoulter.com or 1-800-854-3633 in the United States and Canada.
Initiated
2026-08-12
Root cause
Component design/selection
Distribution
Worldwide - US Nationwide distribution including in the states and territory of CA, NE, FL, NY, MA, MD, SC, WI, TX, OH, VA, PA, IL, NH, KS, GA, NC, IA, PR, TN, OR, UT, NJ, MI, CO, NM, MS, LA, RI, OK, WA, MO, ME, IN, CT, AZ, AR, MT, MN, ID, DE, AL, WV, DC, KY, NV, WY, ND, HI, AK, SD, VT, GU and the countries of Canada, Mexico, Switzerland, Panama, Ecuador, Japan, Hungary, Italy, Belgium, China, Germany, France, United Kingdom of Great Britain and Northern Ireland, Russian Federation, Singapore, Romania, Argentina, Israel, Spain, Belarus, Guatemala, Colombia, Qatar, Czechia, Reunion, Australia, United Arab Emirates, Poland, Croatia, Brazil, Slovakia, New Zealand, Saudi Arabia, Thailand, Republic of Korea, Serbia, Austria, Macao, Ukraine, India, Netherlands, Taiwan, South Africa, Sint Maarten, Bangladesh, Hong Kong, Viet Nam, Bahrain, Uganda, Lebanon, Morocco, Guadeloupe, Greece, Curacao, Republic of Moldova, Malaysia, Ghana, Indonesia, Lithuania, Portugal, Kazakhstan, Georgia, Philippines, Bosnia and Herzegovina, Libya, Kuwait, Oman, Jordan, Uzbekistan.
Recall number
Z-0161-2027
Recall status
Open, Classified
CDRH record ID
222710
FDA classified
2026-10-15
Recall event number
99832

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗